ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,603.40
0.44%
S&P ASX All Technology
2,983.50
0.50%
Brent Oil
83.915
0.45%
US Dollar vs AUD
1.53094
0.00%
Bitcoin
57,271.30
-1.66%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Immunic Inc (IMUX)

  7. Immunic Inc (IMUX) News

IMUX Immunic Inc

1.2709
0.0109 (0.87%)
02 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Immunic Inc IMUX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.0109 0.87% 1.2709 08:33:43
Open Price Low Price High Price Close Price Previous Close
1.29 1.26 1.34 1.30 1.26
more quote information »

Recent News

Date Time Source Heading
01/5/202420:30PRNUSImmunic, Inc. to Announce Financial Results for the First..
30/4/202420:30PRNUSImmunic Announces Publication of Extended Data From Phase 2..
04/4/202421:30PRNUSImmunic to Host MS R&D Day and Participate in Investor..
20/3/202421:30PRNUSImmunic Receives Notice of Allowance for..
09/3/202408:05EDGAR2Form 8-K - Current report
07/3/202422:30PRNUSImmunic to Participate in Investor and Scientific..
07/3/202413:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202413:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202413:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202413:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202413:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202413:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202422:30PRNUSImmunic Presents Data From Phase 2 CALLIPER and CALVID-1..
22/2/202422:38EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/2/202422:35EDGAR2Form 8-K - Current report
22/2/202422:30PRNUSImmunic, Inc. Reports Year End 2023 Financial Results and..
15/2/202422:30PRNUSImmunic, Inc. to Announce Financial Results for the Year..
15/2/202408:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/2/202400:47EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202423:55EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202408:36EDGAR2Form S-3 - Registration statement under Securities Act of..
06/2/202400:30EDGAR2Form DEF 14A - Other definitive proxy statements
01/2/202422:30PRNUSImmunic to Participate in Investor and Scientific..
25/1/202409:05EDGAR2Form PRE 14A - Other preliminary proxy statements
20/1/202408:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202408:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202408:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202408:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202408:05EDGAR2Form D - Notice of Exempt Offering of Securities
17/1/202408:12EDGAR2Form SC 13G - Statement of acquisition of beneficial..
11/1/202401:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
05/1/202422:41EDGAR2Form 8-K - Current report
05/1/202422:35PRNUSImmunic Highlights 2023 Accomplishments and Upcoming..
05/1/202422:30PRNUSImmunic, Inc. Announces Private Placement of up to $240..
22/12/202300:30EDGAR2Form 8-K - Current report
23/11/202308:20EDGAR2Form S-3 - Registration statement under Securities Act of..
21/11/202322:30PRNUSImmunic Receives Notice of Allowance for United States..
14/11/202322:38EDGAR2Form 8-K - Current report
14/11/202322:30PRNUSImmunic, Inc. Reports Third Quarter 2023 Financial Results..
07/11/202322:30PRNUSImmunic to Announce Financial Results for the Third Quarter..
02/11/202321:30PRNUSImmunic Receives Notice of Allowance for United States..
26/10/202321:30PRNUSImmunic to Participate in Scientific and Industry..
19/10/202307:05EDGAR2Form 8-K - Current report
16/10/202321:30PRNUSImmunic Presents Data From Phase 2 CALDOSE-1 Trial of..
15/10/202321:30PRNUSImmunic Presents Data From Phase 1b Clinical Trial of..
11/10/202321:30PRNUSImmunic Presents Data From Phase 2 EMPhASIS Trial of..
10/10/202323:48EDGAR2Form 8-K - Current report
10/10/202307:01PRNUSImmunic Reports Positive Interim Data from Phase 2 CALLIPER..
04/10/202321:30PRNUSImmunic to Participate in Scientific Conferences in October
06/9/202320:30PRNUSImmunic to Participate in Industry and Investor Conferences..

Your Recent History

NASDAQ
IMUX
Immunic
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved